Adagio Medical Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
41
- Stock Symbol
-
ADGM
- Investments
-
1
- Share Price
-
$1.66
- (As of Thursday Closing)
Adagio Medical General Information
Description
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
Contact Information
Website
www.adagiomedical.comCorporate Office
- 26051 Merit Circle
- Suite 102
- Laguna Hills, CA 92653
- United States
Corporate Office
- 26051 Merit Circle
- Suite 102
- Laguna Hills, CA 92653
- United States
Adagio Medical Timeline
Adagio Medical Stock Performance
As of 19-Nov-2026, Adagio Medical’s stock price is $1.66. Its current market cap is $1.63M with 983K shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.66 | $1.52 | $1.45 - $50.70 | $1.63M | 983K | 92.2K | -$4.24 |
Adagio Medical Financials Summary
As of 30-Sep-2026, Adagio Medical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 21,659 | 39,321 | ||
| Revenue | 0 | 0 | 300 | 189 |
| EBITDA | 4,514 | (21,685) | (35,958) | (23,080) |
| Net Income | 822 | (25,084) | (38,146) | (23,673) |
| Total Assets | 29,860 | 43,253 | 6,825 | 8,697 |
| Total Debt | 3,122 | 21,758 | 38,399 | 9,797 |
Adagio Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Adagio Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Adagio Medical Comparisons
Industry
Financing
Details
Adagio Medical Competitors (2)
One of Adagio Medical’s 2 competitors is Emblok, a Private Equity-Backed company based in Tampa, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Emblok | Private Equity-Backed | Tampa, FL | ||||
| JenaValve Technology | Private Equity-Backed | Irvine, CA |
Adagio Medical Patents
Adagio Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026043569-A1 | Energy modulated treatment modality for cryoablation | Pending | 18-Aug-2024 | ||
| WO-2025264468-A1 | Cryoablation catheter with internal inflatable member | Pending | 18-Jun-2024 | ||
| US-20250072950-A1 | Closed loop high pressure generating cryoablation system | Pending | 04-Sep-2023 | ||
| US-20240398460-A1 | Calibration method for contact verification system | Pending | 02-Jun-2023 | ||
| US-12161382-B2 | Flow manifold for cryoablation catheter | Active | 14-Aug-2020 | A61B18/02 |
Adagio Medical Signals
Adagio Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Adagio Medical Acquisitions (1)
Adagio Medical’s most recent deal was a Merger/Acquisition with ARYA Sciences Acquisition IV. The deal was made on 01-Aug-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ARYA Sciences Acquisition IV | 01-Aug-2024 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Adagio Medical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.14 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Adagio Medical FAQs
-
When was Adagio Medical founded?
Adagio Medical was founded in 2011.
-
Where is Adagio Medical headquartered?
Adagio Medical is headquartered in Laguna Hills, CA.
-
What is the size of Adagio Medical?
Adagio Medical has 41 total employees.
-
What industry is Adagio Medical in?
Adagio Medical’s primary industry is Surgical Devices.
-
Is Adagio Medical a private or public company?
Adagio Medical is a Public company.
-
What is Adagio Medical’s stock symbol?
The ticker symbol for Adagio Medical is ADGM.
-
What is the current stock price of Adagio Medical?
As of 19-Nov-2026 the stock price of Adagio Medical is $1.66.
-
What is the current market cap of Adagio Medical?
The current market capitalization of Adagio Medical is $1.63M.
-
Who are Adagio Medical’s competitors?
Emblok and JenaValve Technology are competitors of Adagio Medical.
-
What is Adagio Medical’s annual earnings per share (EPS)?
Adagio Medical’s EPS for 12 months was -$4.24.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process